Bath & Body Works, Inc. — fact timeline

Bath & Body Works, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-11 meeting.

“Advisory Vote on Executive Compensation The compensation of the Company’s named executive officers as described in the Proxy Statement was approved by the Company’s stockholders, on an advisory basis, with 159,868,611 shares voting for the Company’s executive compensation, 4,342,715 shares voting against the Company’s executive compensation, 260,466 shares abstaining and 16,401,324 broker non-votes.”

Bath & Body Works, Inc. shareholders approved Ratification of the Independent Registered Public Accounting Firm at the 2026-06-11 meeting.

“Ratification of the Independent Registered Public Accounting Firm The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was ratified, with 178,656,095 shares voting for the appointment, 2,033,828 shares voting against the appointment and 183,193 shares abstaining.”

Bath & Body Works, Inc. shareholders approved Election of Directors at the 2026-06-11 meeting.

“Election of Directors Alessandro Bogliolo, Lucy O. Brady, Daniel J. Heaf, Francis A. Hondal, Danielle M. Lee, Sarah E. Nash, Juan Rajlin, Stephen D. Steinour, J.K. Symancyk, and Steven E. Voskuil were elected to the Board for a term of one year. Of the 180,873,116 shares present in person or represented by proxy at the meeting, the number of shares voted for, the number of shares voted against, the number of shares abstained and the number of broker non-votes were as follows, with respect to each of the nominees: For Against Abstain Broker Non-Votes Alessandro Bogliolo 156,389,860 7,851,331 230,601 16,401,324 Lucy O. Brady 161,941,704 2,279,447 250,641 16,401,324 Daniel J. Heaf 163,161,351 1,065,753 244,688 16,401,324 Francis A. Hondal 162,546,250 1,696,956 228,586 16,401,324 Danielle M. Lee 161,772,345 2,449,027 250,420 16,401,324 Sarah E. Nash 162,673,795 1,574,595 223,402 16,401,324 Juan Rajlin 161,864,901 2,359,206 247,685 16,401,324 Stephen D. Steinour 160,903,641 3,340,853 227,29”

Bath & Body Works, Inc. reported first quarter 2026 results: revenue $1,378 million, net income $183 million, EPS $0.90.

“The company reported net sales of $1,378 million for the quarter ended May 2, 2026”

Tom Javitch was appointed as Interim Chief Financial Officer at Bath & Body Works, Inc..

“the Board of Directors (the "Board") of the Company approved the appointment of Tom Javitch to serve as the Company’s Interim Chief Financial Officer”

Eva C. Boratto resigned as Chief Financial Officer and Chief Accounting Officer at Bath & Body Works, Inc..

“Ms. Boratto provided notice of her intent to resign from the Company to pursue another professional opportunity, effective as of the Transition Date, on May 20, 2026.”

Bath & Body Works, Inc. reported fiscal 2026 results: EPS $3.00 and $3.25. Guidance initiated.

“For fiscal 2026, the company is forecasting net sales to decline between 4.5% to 2.5% compared to $7,291 million in fiscal 2025. Full-year 2026 earnings per diluted share is expected to be between $3.00 and $3.25 compared to $3.11 in fiscal 2025.”

Bath & Body Works, Inc. reported the year ended January 31, 2026 results: revenue $7,291 million, net income $649 million, EPS $3.11.

“The company reported net sales of $7,291 million for the year ended January 31, 2026, a decrease of 0.2% compared to net sales of $7,307 million for the year ended February 1, 2025. Earnings per diluted share were $3.11 for the year, compared to $3.61 in 2024. Full-year operating income was $1,126 million compared to $1,266 million last year, and net income was $649 million compared to $798 million last year.”

Bath & Body Works, Inc. reported the quarter ended January 31, 2026 results: revenue $2,724 million, net income $403 million, EPS $1.99.

“The company reported net sales of $2,724 million for the quarter ended January 31, 2026, a decrease of 2% compared to net sales of $2,788 million for the quarter ended February 1, 2025. Earnings per diluted share were $1.99 for the fourth quarter of 2025, compared to $2.09 last year. Fourth quarter operating income was $599 million compared to $678 million last year, and net income was $403 million compared to $453 million last year.”

Bath & Body Works, Inc. amended credit facility with JPMorgan Chase Bank, N.A. at SOFR or an alternative base rate ... plus an interest rate margin ranging from ( maturing five years after the closing of the ABL Facility.

“On May 22, 2025, Bath & Body Works entered into an amendment and restatement of its senior secured asset-based revolving credit facility (the "ABL Facility").”

Daniel Heaf was appointed as member of the Board at Bath & Body Works, Inc..

“Mr. Heaf will be appointed as a member of the Board effective as of immediately following the conclusion of the Company’s 2025 Annual Meeting of Shareholders”

Daniel Heaf was appointed as Chief Executive Officer at Bath & Body Works, Inc..

“the Board of Directors of the Company (the “Board”) has appointed Daniel Heaf to serve as Chief Executive Officer of the Company, effective May 16, 2025”

Gina Boswell resigned as member of the Board at Bath & Body Works, Inc..

“resigned as a member of the Board effective the same day”

Gina Boswell resigned as Chief Executive Officer at Bath & Body Works, Inc..

“Gina Boswell ceased to serve as Chief Executive Officer of the Company effective as of May 16, 2025”

Deon Riley departed as Chief Human Resources Officer at Bath & Body Works, Inc..

“Effective on January 31, 2025, Deon Riley ceased to serve as Chief Human Resources Officer of Bath & Body Works, Inc.”

Julie Rosen departed as President, Retail at Bath & Body Works, Inc..

“Julie Rosen ceased to serve as President, Retail of Bath & Body Works, Inc. (the “Company”) on September 25, 2024.”

Thomas J. Kuhn resigned as director at Bath & Body Works, Inc..

“On April 20, 2024, Thomas J. Kuhn notified the Board of Directors (the “Board”) of Bath & Body Works, Inc. (the “Company”) of his resignation of service as a director of the Company, effective the same date.”

Michael G. Morris departed as Director at Bath & Body Works, Inc..

“each of Patricia S. Bellinger and Michael G. Morris notified Bath & Body Works, Inc. (the “Company”) of their decision not to stand for re-election to the Company’s Board of Directors following expiration of their current term at the Company’s 2024 Annual Meeting of Stockholders.”

Patricia S. Bellinger departed as Director at Bath & Body Works, Inc..

“each of Patricia S. Bellinger and Michael G. Morris notified Bath & Body Works, Inc. (the “Company”) of their decision not to stand for re-election to the Company’s Board of Directors following expiration of their current term at the Company’s 2024 Annual Meeting of Stockholders.”

Bath & Body Works, Inc. updated its fiscal 2024 guidance (initiated).

“For fiscal 2024, the company is forecasting net sales to range between a decline of 3.0% to flat relative to $7.429 billion of net sales in fiscal 2023.”

Bath & Body Works, Inc. reported 53-week fiscal year ended Feb. 3, 2024 results: revenue $7.429 billion, net income $878 million, EPS $3.84.

“Net sales decreased 1.7% to $7.429 billion for the 53-week fiscal year ended Feb. 3, 2024, compared to $7.560 billion for the 52-week fiscal year ended Jan. 28, 2023.”

Bath & Body Works, Inc. reported 14-week fourth quarter ended Feb. 3, 2024 results: revenue $2.912 billion, net income $579 million, EPS $2.55.

“The company reported net sales of $2.912 billion for the 14-week fourth quarter ended Feb. 3, 2024, an increase of 0.8% compared to net sales of $2.889 billion for the 13-week fourth quarter ended January 28, 2023.”

Bath & Body Works, Inc. updated its fiscal 2023 guidance (raised).

“The company now expects full-year 2023 earnings per diluted share to be between $2.99 and $3.19, compared to $3.40 in 2022.”

Bath & Body Works, Inc. reported third quarter ended October 28, 2023 results: revenue $1.562 billion, net income $119 million, EPS $0.52. Guidance raised.

“The company reported net sales of $1.562 billion for the third quarter ended October 28, 2023, a decrease of 2.6% compared to net sales of $1.604 billion for the third quarter ended October 29, 2022.”

Bath & Body Works, Inc. reported fiscal 2023 results: EPS $2.85 and $3.15. Guidance raised.

“The company now expects full-year 2023 earnings per diluted share to be between $2.85 and $3.15”

Bath & Body Works, Inc. reported second quarter ended July 29, 2023 results: revenue $1.559 billion, net income $99 million, EPS $0.43. Guidance raised.

“The company reported net sales of $1.559 billion for the second quarter ended July 29, 2023”

Wendy C. Arlin departed as Chief Financial Officer at Bath & Body Works, Inc..

“Wendy C. Arlin will cease serving as Chief Financial Officer effective as of July 29, 2023.”

Eva C. Boratto was appointed as Chief Financial Officer at Bath & Body Works, Inc..

“appointed Eva C. Boratto as the Chief Financial Officer of the Company effective as of August 1, 2023.”

Bath & Body Works, Inc. shareholders rejected Stockholder Proposal Regarding an Independent Board Chair at the 2023-06-08 meeting.

“The stockholder proposal regarding an independent board chair was rejected by the Company’s stockholders, with 61,346,765 shares voting for the proposal, 129,408,480 shares voting against the proposal, 1,251,187 shares abstaining and 13,546,487 broker non-votes.”

Bath & Body Works, Inc. shareholders approved Advisory Vote to Determine the Frequency of Future Advisory Votes on Executive Compensation at the 2023-06-08 meeting.

“The stockholders adopted, on an advisory basis, the option to hold an advisory vote on executive compensation every year, with a vote of 189,743,395 shares in favor of holding the advisory vote every year, 80,220 shares in favor of holding the advisory vote every two years and 1,626,667 shares in favor of holding the advisory vote every three years, with 556,149 shares abstaining and 13,546,487 broker non-votes.”

Bath & Body Works, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-06-08 meeting.

“The compensation of the Company’s named executive officers as described in the Proxy Statement was approved by the Company’s stockholders, on an advisory basis, with 130,660,460 shares voting for the Company’s executive compensation, 60,621,868 shares voting against the Company’s executive compensation, 724,103 shares abstaining and 13,546,487 broker non-votes.”

Bath & Body Works, Inc. shareholders approved Ratification of the Independent Registered Public Accountants at the 2023-06-08 meeting.

“The appointment of Ernst & Young LLP as the Company’s independent registered public accountants for the 2023 fiscal year was ratified, with 200,475,474 shares voting for the appointment, 3,965,683 shares voting against the appointment and 1,111,762 shares abstaining.”

Bath & Body Works, Inc. shareholders approved Election of Directors at the 2023-06-08 meeting.

“Election of Directors Patricia S. Bellinger, Alessandro Bogliolo, Gina R. Boswell, Lucy O. Brady, Francis A. Hondal, Thomas J. Kuhn, Danielle M. Lee, Michael G. Morris, Sarah E. Nash, Juan Rajlin, Stephen D. Steinour, J.K. Symancyk and Steven E. Voskuil were elected to the Board of Directors of the Company (the “Board”) for a term of one year. Of the 205,552,918 shares present in person or represented by proxy at the meeting, the number of shares voted for, the number of shares voted against, the number of shares abstained and the number of broker non-votes were as follows, with respect to each of the nominees: For Against Abstain Broker Non-Votes Patricia S. Bellinger 183,474,788 7,850,433 681,211 13,546,487 Alessandro Bogliolo 188,659,393 2,660,331 686,708 13,546,487 Gina R. Boswell 190,761,740 569,656 675,036 13,546,487 Lucy O. Brady 190,809,151 517,054 680,226 13,546,487 Francis A. Hondal 188,598,309 2,735,048 673,075 13,546,487 Thomas J. Kuhn 190,705,417 543,593 757,422 13,546,487”

Bath & Body Works, Inc. reported first quarter ended April 29, 2023 results: revenue $1.396 billion, net income $81 million, EPS $0.35. Guidance raised.

“The company reported net sales of $1.396 billion for the first quarter ended April 29, 2023, a decrease of 4% compared to net sales of $1.450 billion for the first quarter ended April 30, 2022. The company reported earnings per diluted share of $0.35 for the first quarter of 2023, compared to $0.64 for the same period of the prior year. First quarter operating income was $181 million compared to $280 million last year, and net income was $81 million compared to $155 million last year.”

Wendy C. Arlin departed as Chief Financial Officer at Bath & Body Works, Inc..

“Wendy C. Arlin will cease to serve as Chief Financial Officer of the Company effective July 29, 2023”

Thomas J. Kuhn was appointed as Director at Bath & Body Works, Inc..

“On March 5, 2023, the Board of Directors (the “Board”) of Bath & Body Works, Inc. (the “Company”) appointed Thomas J. Kuhn as an independent director of the Company effective as of March 10, 2023.”

Bath & Body Works, Inc. reported fiscal 2023 results: EPS between $2.50 and $3.00. Guidance initiated.

“For fiscal 2023, the company is forecasting flat net sales to a mid-single digit decline compared to $7.560 billion in 2022. Full-year 2023 earnings from continuing operations per diluted share is expected to be between $2.50 and $3.00, compared to $3.40 in 2022. Fiscal 2023 will include a 53 rd week, with the fourth quarter of fiscal 2023 consisting of 14 weeks. The company’s full-year outlook includes the impact of the 53 rd week, estimated at 7 cents per diluted share.”

Bath & Body Works, Inc. reported the first quarter of fiscal 2023 results: EPS between $0.17 and $0.27. Guidance initiated.

“The company expects first quarter net sales to decline low- to mid-single digits compared to $1.450 billion in 2022. First quarter earnings from continuing operations per diluted share are expected to be between $0.17 and $0.27, compared to $0.64 earnings from continuing operations per diluted share in the first quarter of 2022.”

Bath & Body Works, Inc. reported the year ended Jan. 28, 2023 results: revenue $7.560 billion, net income $794 million, EPS $3.40.

“Net sales from continuing operations decreased 4% to $7.560 billion for the year ended Jan. 28, 2023, compared to $7.882 billion for the year ended Jan. 29, 2022. The company reported earnings from continuing operations per diluted share of $3.40 for the year, compared to $3.94 in 2021. Full-year operating income was $1.376 billion compared to $2.009 billion last year, and net income from continuing operations was $794 million compared to $1.075 billion last year.”

Bath & Body Works, Inc. reported the fourth quarter ended Jan. 28, 2023 results: revenue $2.889 billion, net income $428.2 million, EPS $1.86.

“The company reported net sales of $2.889 billion for the fourth quarter ended Jan. 28, 2023, a decrease of 5% compared to net sales of $3.027 billion for the fourth quarter ended Jan. 29, 2022. The company reported earnings from continuing operations per diluted share of $1.86 for the fourth quarter of 2022, compared to $2.27 for the same period of the prior year. Fourth quarter operating income was $652.7 million compared to $879.2 million last year, and net income from continuing operations was $428.2 million compared to $592.6 million last year.”

Steven E. Voskuil was appointed as director at Bath & Body Works, Inc..

“On February 20, 2023, the Board of Directors (the “Board”) of Bath & Body Works, Inc. (the “Company”) appointed Steven E. Voskuil as an independent director of the Company effective as of February 21, 2023.”

Lucy Brady was appointed as independent director at Bath & Body Works, Inc..

“On February 12, 2023, the Board of Directors (the “Board”) of Bath & Body Works, Inc. (the “Company”) appointed Lucy Brady as an independent director of the Company.”

Bath & Body Works, Inc. reported third quarter ended Oct. 29, 2022 results: revenue $1.60 billion, net income $91.0 million, EPS $0.40. Guidance raised.

“The company reported net sales of $1.60 billion for the third quarter ended Oct. 29, 2022, a decrease of 5% compared to net sales of $1.68 billion for the third quarter ended Oct. 30, 2021, but an increase of 46% compared to the third quarter of 2019. The company reported earnings from continuing operations per diluted share of $0.40 for the third quarter ended Oct. 29, 2022, compared to $0.66 for the quarter ended Oct. 30, 2021. Third quarter operating income was $201.8 million compared to $408.5 million last year, and net income from continuing operations was $91.0 million compared to $177.1 million last year.”

Sarah E. Nash changed role as non-executive Chair of the Board at Bath & Body Works, Inc..

“Sarah E. Nash will cease serving as Interim Chief Executive Officer effective as of December 1, 2022 and as Executive Chair of the Board as of the end of the Company’s fiscal year on January 28, 2023, at which time she will transition to non-executive Chair of the Board.”

Gina Boswell was appointed as member of the Board at Bath & Body Works, Inc..

“The Company also announced that Ms. Boswell will be appointed as a member of the Board on December 1, 2022.”

Gina Boswell was appointed as Chief Executive Officer at Bath & Body Works, Inc..

“On November 2, 2022, Bath & Body Works, Inc. (the “Company”) announced that the Board of Directors (the “Board”) of the Company appointed Gina Boswell as the Chief Executive Officer of the Company effective as of December 1, 2022.”

Chris T. Cramer resigned as Chief Operating Officer at Bath & Body Works, Inc..

“On August 15, 2022, Chris T. Cramer, the Company’s Chief Operating Officer, notified the Company of his decision to resign from the Company to pursue other opportunities effective on August 17, 2022.”

James L. Bersani departed as President, Real Estate at Bath & Body Works, Inc..

“James L. Bersani, President, Real Estate of the Company, announced his retirement from the Company, effective as of October 7, 2022.”

Robert H. Schottenstein retired as member of the Board at Bath & Body Works, Inc..

“Robert H. Schottenstein also retired from the Board on May 12, 2022, at the conclusion of the Annual Meeting.”

Sarah E. Nash was appointed as Interim Chief Executive Officer at Bath & Body Works, Inc..

“Sarah E. Nash, Executive Chair of the Company, was appointed to also serve as Interim Chief Executive Officer of the Company.”